Article citationsMore>>

Topalian, S.L., Bhatia, S., Hollebecque, A., et al. (2022) Non-Comparative, Open-Label, Multiple Cohort, Phase 1/2 Study of Nivolumab in Patients with Advanced Merkel Cell Carcinoma: Updated Survival Outcomes. Cancer, 128, 3349-3358.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top